nicorandil has been researched along with Kidney Diseases in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.56) | 18.2507 |
| 2000's | 1 (5.56) | 29.6817 |
| 2010's | 8 (44.44) | 24.3611 |
| 2020's | 8 (44.44) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, P; Jin, L; Luo, S; Mei, Z; Zhang, Q; Zhou, L; Zhu, C; Zhu, H | 1 |
| Bhatnagar, A; Bhatt, AN; Kakkar, D; Karwasra, R; Khanna, K; Nishad, DK; Rai, Y; Sharma, A; Sharma, N | 1 |
| Abdollahi Moghaddam, A; Babalhekam, SA; Baradaran Rahimi, V; Morovatdar, N; Rezaee, R | 1 |
| Fan, Z; Ji, H; Jian, X; Li, Y | 1 |
| Alkatiri, AA; Firman, D; Lukito, AA; Pranata, R; Vania, R | 1 |
| Daggubati, R; Ghaffar, YA | 1 |
| Fu, N; Li, Y; Zeng, Z; Zhang, H; Zhang, P | 1 |
| Chen, X; Jiang, Y; Luo, J; Mo, S; Rong, J; Yi, B; Yi, D | 1 |
| Jiao, Z; Li, X; Ma, X; Zhang, Y | 1 |
| Hu, Q; Li, S; Liu, Y; Wang, L | 1 |
| Li, Y; Liu, H; Peng, W; Song, Z | 1 |
| Cong, HL; Fu, NK; Li, WY; Lin, WH; Liu, XG; Lu, CZ; Tian, FS; Yang, SC; Zhang, J; Zhang, P; Zhang, X | 1 |
| Cho, YH; Choi, SH; Hong, MK; Jang, Y; Kang, WC; Kim, JY; Ko, YG; Kwon, HM; Lee, BK; Min, PK; Moon, JY | 1 |
| Cai, J; Du, R; Fan, Y; Li, Y; Lin, S; Lv, J; Shi, Y; Wang, X; Wei, Q; Yao, L; Zhang, Y; Zhou, B | 1 |
| Hashimoto, T; Imai, R; Iwamoto, N; Kobayashi, H; Nishida, M; Nishimura, M; Okino, K; Ono, T; Takahashi, H; Tokoro, T; Yamazaki, S | 1 |
| Hamono, T; Inoue, K; Isaka, Y; Kawada, N; Kimura, T; Kitamura, H; Matsui, I; Nagasawa, Y; Obi, Y; Rakugi, H; Sakata, Y; Shinzawa, M | 1 |
| Aizawa, K; Hirata, M; Ishizuka, N; Koike, N; Serizawa, K; Tashiro, Y; Yogo, K | 1 |
| Molinaro, M; Regazzi, MB; Rondanelli, R; Salvadeo, A; Sartirana, E; Segagni, S; Villa, G | 1 |
5 review(s) available for nicorandil and Kidney Diseases
| Article | Year |
|---|---|
Efficacy of brain natriuretic peptide
Topics: Contrast Media; Creatinine; Humans; Kidney Diseases; Natriuretic Peptide, Brain; Network Meta-Analysis; Nicorandil; Nitroglycerin; Percutaneous Coronary Intervention | 2022 |
Nicorandil Reduces the Incidence of Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography/Intervention - Systematic Review and Meta-Analysis of Randomized Controlled Trials Including GRADE Qualification.
Topics: Contrast Media; Coronary Angiography; Humans; Incidence; Kidney Diseases; Nicorandil; Percutaneous Coronary Intervention; Randomized Controlled Trials as Topic | 2020 |
Nicorandil for the prevention of contrast-induced nephropathy: A meta-analysis of randomized controlled trials.
Topics: Aged; Chi-Square Distribution; Contrast Media; Female; Humans; Incidence; Kidney Diseases; Male; Middle Aged; Nicorandil; Odds Ratio; Protective Factors; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Treatment Outcome | 2018 |
Preventive effect of nicorandil on contrast-induced nephropathy: a meta-analysis of randomised controlled trials.
Topics: Contrast Media; Coronary Angiography; Databases, Factual; Glomerular Filtration Rate; Humans; Kidney Diseases; Nicorandil; Percutaneous Coronary Intervention; Randomized Controlled Trials as Topic; Vasodilator Agents | 2018 |
Nicorandil improves clinical outcomes in patients with stable angina pectoris requiring PCI: a systematic review and meta-analysis of 14 randomized trials.
Topics: Angina, Stable; Anti-Arrhythmia Agents; Contrast Media; Coronary Artery Disease; Humans; Kidney Diseases; Myocardial Infarction; Nicorandil; Percutaneous Coronary Intervention; Randomized Controlled Trials as Topic | 2018 |
7 trial(s) available for nicorandil and Kidney Diseases
| Article | Year |
|---|---|
Oral Nicorandil effectively attenuates the incidence of contrast-induced nephropathy in patients undergoing cardiac catheterization: a randomized, controlled, open-label clinical trial.
Topics: Cardiac Catheterization; Contrast Media; Coronary Angiography; Creatinine; Female; Humans; Incidence; Kidney Diseases; Male; Nicorandil; Saline Solution | 2023 |
Efficacy of Oral Nicorandil to Prevent Contrast-Induced Nephropathy in Patients with Chronic Renal Dysfunction Undergoing an Elective Coronary Procedure.
Topics: Aged; Cardiac Surgical Procedures; Contrast Media; Coronary Angiography; Creatinine; Cystatin C; Elective Surgical Procedures; Female; Glomerular Filtration Rate; Humans; Hypodermoclysis; Kidney Diseases; Male; Middle Aged; Nicorandil; Renal Insufficiency, Chronic | 2019 |
Standard vs. double dose of intravenous nicorandil in preventing contrast-induced nephropathy in patients with coronary heart disease undergoing elective coronary procedures.
Topics: Administration, Intravenous; Aged; China; Contrast Media; Coronary Disease; Creatinine; Female; Humans; Kidney Diseases; Male; Nicorandil; Prospective Studies; Single-Blind Method | 2021 |
Preventive Effects of Nicorandil Against Contrast-Induced Nephropathy in Patients With Moderate Renal Insufficiency Undergoing Percutaneous Coronary Intervention.
Topics: Aged; Contrast Media; Female; Humans; Kidney Diseases; Male; Nicorandil; Percutaneous Coronary Intervention; Renal Insufficiency; Severity of Illness Index | 2020 |
Preventive effect of pretreatment with intravenous nicorandil on contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography (PRINCIPLE Study).
Topics: Administration, Intravenous; Aged; Contrast Media; Coronary Angiography; Creatinine; Female; Glomerular Filtration Rate; Humans; Incidence; Kidney Diseases; Male; Middle Aged; Nicorandil | 2013 |
Preventive effect of oral nicorandil on contrast-induced nephropathy in patients with renal insufficiency undergoing elective cardiac catheterization.
Topics: Administration, Oral; Aged; Biomarkers; Cardiac Catheterization; Chi-Square Distribution; China; Contrast Media; Coronary Angiography; Creatinine; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Iohexol; Kidney; Kidney Diseases; Logistic Models; Male; Middle Aged; Multivariate Analysis; Nicorandil; Odds Ratio; Percutaneous Coronary Intervention; Protective Agents; Radiography, Interventional; Renal Insufficiency; Risk Factors; Time Factors; Treatment Outcome; Up-Regulation | 2016 |
Effects of nicorandil on the reduction of BNP levels in patients with chronic kidney disease.
Topics: Administration, Oral; Aged; Blood Pressure; Cardiovascular Diseases; Chronic Disease; Down-Regulation; Endothelium, Vascular; Female; Humans; Japan; Kidney Diseases; Linear Models; Male; Middle Aged; Natriuretic Peptide, Brain; Nicorandil; Peritoneal Dialysis; Prospective Studies; Pulsatile Flow; Regional Blood Flow; Time Factors; Treatment Outcome; Vasodilator Agents | 2011 |
6 other study(ies) available for nicorandil and Kidney Diseases
| Article | Year |
|---|---|
Protective Effect of Organ Preservation Fluid Supplemented With Nicorandil and Rutin Trihydrate: A Comparative Study in a Rat Model of Renal Ischemia.
Topics: Adenosine Triphosphate; Animals; Caspase 3; HEK293 Cells; Humans; Ischemia; Kidney Diseases; Nicorandil; Organ Preservation; Rats; Reactive Oxygen Species; Rutin; Treatment Outcome | 2022 |
Nicorandil for CIN Prevention - A Hope or Hype?
Topics: Contrast Media; Coronary Angiography; Humans; Incidence; Kidney Diseases; Nicorandil; Randomized Controlled Trials as Topic | 2020 |
Efficacy and Safety of Nicorandil in Preventing Contrast-Induced Nephropathy after Elective Percutaneous Coronary Intervention: A Pooled Analysis of 1229 Patients.
Topics: Aged; Contrast Media; Drug-Related Side Effects and Adverse Reactions; Elective Surgical Procedures; Female; Humans; Incidence; Kidney Diseases; Male; Middle Aged; Nicorandil; Percutaneous Coronary Intervention; Vasodilator Agents | 2020 |
Clinical potential of nicorandil to inhibit major cardiac events in hemodialysis patients with suspected myocardial ischemia.
Topics: Aged; Death; Female; Follow-Up Studies; Humans; Kidney Diseases; Male; Middle Aged; Myocardial Ischemia; Nicorandil; Renal Dialysis | 2009 |
Nicorandil ameliorated hypertensive renal injury without lowering blood pressure in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Hypertension; Kidney Diseases; Male; Nicorandil; Nitric Oxide Synthase Type III; Proteinuria; Rats; Rats, Inbred SHR; Rats, Inbred WKY; RNA, Messenger | 2013 |
Pharmacokinetics of nicorandil in patients with normal and impaired renal function.
Topics: Administration, Oral; Adult; Aged; Antihypertensive Agents; Female; Half-Life; Humans; Kidney Diseases; Male; Metabolic Clearance Rate; Middle Aged; Niacinamide; Nicorandil; Vasodilator Agents | 1992 |